glp 1 agonist contraindication Incretins: How we got here, where we're at and what is coming next GLP-1 Receptor Agonists: antidiabetic and
Description
To access our library of previously recorded activities, visit watch.houstonmethodist.org
Try PeptideComfort today and take control of your GLP-1 therapy journey with a supplement designed to work as hard as you do
GLP-1 medications are changing how people think about weight loss and how they actually lose weight, driving changes in views about obesity care among health systems and providers and affecting the broader US economy. These drugs hold the potential to help address what continues to be an increasing obesity problem in the US. A 2024 []
Our findings strongly suggest the answer is yes. Primes recent real-world study found 63% of high-potency GLP-1 (Wegovy or Zepbound) users who started treatment in Q1 2024 are still taking their medication after a year
